(2024) Corrigendum to “The prophylaxis and treatment potential of supplements for COVID-19” Eur. J. Pharmacol. 887 (15 November 2020) 173530 (European Journal of Pharmacology (2020) 887, (S0014299920306221), (10.1016/j.ejphar.2020.173530)). European Journal of Pharmacology. ISSN 00142999 (ISSN)
Full text not available from this repository.
Abstract
The authors regret the error in the original article's wording. The corrected sentence would be as follows: "a cross-sectional analysis reported a negative relationship between the average vitamin D levels and the number of COVID positive cases (P = 0.050), and also the rate of COVID–19 mortality (P = 0.05) (Ilie et al., 2020)". It is essential to note that these corrections do not impact the final conclusions drawn. The authors express their regret for any confusion caused and extend their heartfelt appreciation to the readers for their understanding and support. © 2024 Elsevier B.V.
Item Type: | Article |
---|---|
Keywords: | vitamin D adjuvant therapy adult article confusion coronavirus disease 2019 cross-sectional study human mortality pharmacology prophylaxis surgery therapy drug therapy erratum |
Journal or Publication Title: | European Journal of Pharmacology |
Journal Index: | Scopus |
Volume: | 972 |
Identification Number: | https://doi.org/10.1016/j.ejphar.2024.176571 |
ISSN: | 00142999 (ISSN) |
Depositing User: | ms soheila Bazm |
URI: | http://eprints.ssu.ac.ir/id/eprint/33293 |
Actions (login required)
View Item |